Shirley Pang

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +4

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee

Thomas J. Schnitzer, Richard Easton, Shirley Pang et al. · JAMA · 2019 · 200 citations · Full text

Medicine, Orthopaedic Surgery, Pharmacotherapy +16

The challenges of transferring chronic illness patients to adult care: reflections from pediatric and adult rheumatology at a US academic center

Aimee O. Hersh, Shirley Pang, Megan L. Curran et al. · Pediatric Rheumatology · 2009 · 83 citations · Full text

Medicine, Clinical Sciences, Pediatrics +17

Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials

Alan Kivitz, Oliver FitzGerald, Peter Nash et al. · Clinical Rheumatology · 2021 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13